$167.64 +1.14 (%) C R Bard Inc - NYSE

Nov. 24, 2014 | 02:10 PM

Partner Headlines

  1. Becton, Dickinson and Co. (BDX) Dividend Stock Analysis

    GuruFocus | Nov. 19, 2014 | 12:37PM EST
  2. Weekly 52-Week Highs Highlight: LBTYK, STZ, FISV, BCR

    GuruFocus | Nov. 9, 2014 | 01:57AM EST
  3. Earnings Scheduled For October 22, 2014

    Benzinga | Oct. 22, 2014 | 05:16AM EST
  4. Dividend Aristocrats In Focus Part 19 of 54: CR Bard

    GuruFocus | Oct. 15, 2014 | 12:45PM EST
  5. The Lutonix® 035 Drug Coated Balloon Is The First And Only FDA-Approved DCB Available In The U.S. For The Treatment Of Femoropopliteal Occlusive Disease

    Benzinga | Oct. 10, 2014 | 09:27AM EST
  6. UPDATE: Bank Of America Downgrades C.R. Bard

    Benzinga | Jul. 30, 2014 | 09:03AM EST
  7. Earnings Scheduled For July 24, 2014

    Benzinga | Jul. 24, 2014 | 05:31AM EST
  8. UPDATE: S&P Capital Downgrades C.R. Bard On Revised 2014 EPS Estimate

    Benzinga | Jun. 20, 2014 | 10:12AM EST
  9. Headwinds For C.R. Bard, According To Barclays

    Benzinga | Jun. 18, 2014 | 10:54AM EST
  10. Benzinga's Top Downgrades

    Benzinga | Jun. 18, 2014 | 07:56AM EST
  11. Morgan Stanley Remains Concerned About C.R. Bard

    Benzinga | Jun. 13, 2014 | 08:50AM EST
  12. Stocks To Watch For June 12, 2014

    Benzinga | Jun. 12, 2014 | 04:19AM EST
  13. Becton, Dickinson and Co. (BDX) Dividend Stock Analysis

    GuruFocus | May. 30, 2014 | 12:32PM EST
  14. Morgan Stanley Still Sees Acceleration Risk for C.R. Bard

    Benzinga | Apr. 23, 2014 | 10:28AM EST
  15. Earnings Scheduled For April 22, 2014

    Benzinga | Apr. 22, 2014 | 05:14AM EST
  16. UPDATE: Bank of America Downgrades C.R. Bard on Multiple Factors

    Benzinga | Apr. 8, 2014 | 08:56AM EST
  17. Yacktman Funds Comments on C.R. Bard Inc.

    GuruFocus | Mar. 12, 2014 | 10:51AM EST
  18. Bard Announces $500M Share Repurchase Authorization

    Benzinga | Jan. 30, 2014 | 16:09PM EST
  19. Yacktman Fund Comments on C.R. Bard Inc.

    GuruFocus | Jan. 30, 2014 | 12:06PM EST
  20. Earnings Scheduled For January 30, 2014

    Benzinga | Jan. 30, 2014 | 04:54AM EST
  21. Risk and Cycles: Looking at Buybacks, Debt, Cash

    YCharts | Jan. 28, 2014 | 18:01PM EST
  22. Weekly Insider Sells Highlight: BCR, GLUU, AMT, APOL, JACK

    GuruFocus | Jan. 20, 2014 | 10:56AM EST
  23. Anti-Elitism: Beating The Dividend Aristocrats

    YCharts | Dec. 12, 2013 | 16:32PM EST
  24. UPDATE: Goldman Sachs Upgrades C.R. Bard as Elements Driving Sell Thesis are Resolved

    Benzinga | Oct. 23, 2013 | 10:09AM EST
  25. UPDATE: Piper Jaffray Upgrades C.R. Bard on Improving Organic Growth Profile, PVD Market Exposure

    Benzinga | Oct. 23, 2013 | 10:07AM EST
  26. Benzinga's Top Upgrades

    Benzinga | Oct. 23, 2013 | 07:49AM EST
  27. C.R. Bard Rises After Q3 Earnings Beat (BCR)

    Benzinga | Oct. 22, 2013 | 16:27PM EST
  28. Earnings Scheduled For October 22, 2013

    Benzinga | Oct. 22, 2013 | 04:49AM EST
  29. UPDATE: Citigroup Raises PT on C.R. Bard on Adjusted BCR Estimates

    Benzinga | Oct. 14, 2013 | 11:47AM EST
  30. CryoLife Says Will Receive ~$15.1M Related to Purchase of Medafor by CR Bard

    Benzinga | Oct. 7, 2013 | 08:37AM EST
  31. Market Wrap For Wednesday, September 4: Markets Increase Slightly As M&As Continue To Rise

    Benzinga | Sep. 4, 2013 | 18:33PM EST
  32. Benzinga's M&A Chatter for Wednesday September 4, 2013

    Benzinga | Sep. 4, 2013 | 17:52PM EST
  33. Morning Market Movers

    Benzinga | Sep. 4, 2013 | 10:00AM EST
  34. Benzinga's Top Pre-Market Gainers

    Benzinga | Sep. 4, 2013 | 08:07AM EST
  35. UPDATE: Bard to Purchase Rochester Medical at $20/Share, or ~$262M Deal

    Benzinga | Sep. 4, 2013 | 07:10AM EST
  36. UPDATE: Bank of America Raises PT on C.R. Bard Following CEO/CFO Meetings

    Benzinga | Aug. 29, 2013 | 11:30AM EST
  37. St. Jude acquires new tech

    IBD | Aug. 19, 2013 | 18:48PM EST
  38. St. Jude, C.R. Bard Make Medical Device Acquisitions

    IBD | Aug. 19, 2013 | 12:06PM EST
  39. CR Bard Announces Deal to Buy Medafor for $200M; Sees Deal Dilutive to Adj. EPS in FY13, Neutral in FY14

    Benzinga | Aug. 19, 2013 | 08:03AM EST
  40. UPDATE: Citigroup Reiterates Neutral Rating, Lowers PT on C.R. Bard

    Benzinga | Feb. 1, 2013 | 07:38AM EST
  41. UPDATE: BMO Capital Markets Reiterates Market Perform Rating, Lowers PT on C.R. Bard

    Benzinga | Feb. 1, 2013 | 03:22AM EST
  42. UPDATE: C.R. Bard Q4 Profit Rises 13%

    Benzinga | Jan. 31, 2013 | 21:10PM EST
  43. UPDATE: Morgan Stanley Downgrades C.R. Bard to Underweight on Lagging Organic Growth

    Benzinga | Jan. 3, 2013 | 01:50AM EST
  44. Donald Yacktman Finds Two Undervalued Companies in His Most Bought, In-Favor Sector of Q3

    GuruFocus | Dec. 4, 2012 | 08:54AM EST
  45. Medical Device Makers: Repeal the New Tax!

    FoxBusiness | Nov. 28, 2012 | 01:43AM EST
  46. Benzinga's Top Initiations

    Benzinga | Nov. 20, 2012 | 01:52AM EST
  47. Steven Cohen's SAC Capital Advisors Q3 Updates: Buys Fossil, Fastenal Company and C.R. Bard

    GuruFocus | Nov. 19, 2012 | 08:59AM EST
  48. C.R. Bard Inc. Reports Operating Results (10-Q)

    GuruFocus | Oct. 24, 2012 | 13:34PM EST
  49. Bard Acquires Neomend For $140M

    Benzinga | Oct. 23, 2012 | 10:35AM EST
  50. Earnings Scheduled For October 23, 2012

    Benzinga | Oct. 22, 2012 | 20:47PM EST
Trading Center